Tagged with Researc

France France – one of the most influential countries in the development of gene therapy– still stands as a global powerhouse in the field, with top-class institutions, a dense network of expertise and increasing political support. However, financing and manufacturing French gene therapies is proving an issue, meaning that France is…

Korea The nation of South Korea has overtaken many of its regional counterparts to boast a highly impressive biosimilars pipeline. Here, key stakeholders in Korean biologics and biosimilars explain how.   Once we chose to specialise in biosimilars, there was no room to survive if we failed with the few projects…

Opinion Dr Kamala Maddali looks at how artificial intelligence is currently being utilized across the healthcare spectrum and why the time is now for Big Pharma to adopt this technology more fully.   The beauty of artificial intelligence is that it allows one to assess both forest and tree.   A…

Sweden Olav Fromm, managing director of Chiesi Nordics, explains the deep roots of Chiesi in Sweden, where its blockbuster drug, a surfactant for treating neonatal babies, was developed. He also touches upon the strategic importance of the region to Chiesi, with the recent creation of a fully-fledged Nordic subsidiary, which will…

Puerto Rico Lucy Crespo, CEO of the Puerto Rico Science, Technology & Research Trust, takes stock of the Trust’s main achievements since outlining its strategic plan in 2015. She also highlights her future ambitions of strengthening the Puerto Rican entrepreneurship and research ecosystem, through start-up acceleration programs and grants, with the ultimate…

Taiwan Dr Fuh-Sheng Shieu, president of National Chung Hsing University, elaborates on his ambitions to further NCHU’s positioning as one of Taiwan’s most impactful research universities. He goes on to highlight NCHU’s capacity to nurture translational research projects, which through the university’s strong academia-industry collaboration, achieve commercial success. Dr Shieu also…

Puerto Rico Puerto Rico has long been known for its pharma manufacturing prowess, but multinational companies are increasingly looking to conduct clinical trials there, thanks to strong institutional support, a strong example set by R&D-focused university spin-off companies, and the island’s unique ethnic profile.   The Hispanic population has been historically underrepresented…

Taiwan Professor Shih-Hua Lin, president of Taiwan’s National Defense Medical Center, shares an overview of the academic and research environment of the institute as well as its role in cultivating the internationally connected talent that will drive Taiwan’s biomedical industry forward.   We must focus on how we can continue international…

Puerto Rico Leobardo Hidalgo, who lived in Puerto Rico as a child, recently came back to the island to head commercial operations at the local BMS affiliate, which has been performing remarkably well. He highlights a portfolio of transformational medicines matched with the local team’s patient-centric approach and knowledge of the ecosystem…

Sweden Medivir is a Swedish biotech company focusing on the development and commercialization of innovative treatments for cancers of high unmet medical need. Last October, Dr Uli Hacksell was appointed CEO to reorganize the company in order to focus resources on the clinical development of Medivir’s projects. He presents the progress…

Taiwan Susan Hsu, managing director of Taiwanese data-driven CRO StatPlus, speaks about the key trends impacting Taiwan’s clinical trial environment and goes on to share her views on the increasing attractiveness of the island. Hsu concludes by explaining the service provider’s strategic position within APAC and its unique strength as a…

Thailand Dr Somvong Tragoonrung, executive director of BIOTEC, one of the first biotechnology-focused research institutes in Thailand, highlights their current research in biotechnology and genomics projects, as well as the local and international collaboration they have in place to further develop the strengths of Thailand in the field.   Currently, estimations…